Coronary Sinus Occlusion Articles & Analysis
4 news found
Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO® (Pressure-controlled intermittent Coronary Sinus Occlusion) therapy as an adjunct to conventional primary percutaneous coronary intervention (PCI) for patients presenting with inferior ...
Miracor Medical Miracor Medical developed the Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) therapy to be used during percutaneous coronary intervention in patients with acute myocardial infarction. ...
PiCSO therapy (Pressure-Controlled Intermittent Coronary Sinus Occlusion) is delivered by interventional cardiologists during the primary PCI (Percutaneous Coronary Intervention) procedure in patients experiencing anterior ST-elevated myocardial infarction (STEMI). ...
The PiCSO clinical results will be presented during two different sessions, including a Hotline session: Thursday May 24th @ 11:03 in the "Hotline Coronary Intervention" session, Room Maillot "OXAMI-PICSO: index of microcirculatory resistance-guided therapy with pressure control intermittent coronary sinus occlusion improves ...